Skip to content

Clinical trials

Phase 2 Hematologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 2 Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20042
20052
20063
20075
20083
20099
20105
20116
20124
20136
20148
20154
20163
20175
20184
20192
20203
20218
20227
20232
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Terminated21
Unknown status11
Active, not recruiting10
Withdrawn6
Recruiting4
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center12
Seagen Inc.12
National Heart, Lung, and Blood Institute (NHLBI)8
Nanfang Hospital, Southern Medical University4
Novartis Pharmaceuticals4
Emory University3
Fred Hutchinson Cancer Center3
H. Lee Moffitt Cancer Center and Research Institute3
Institute of Hematology & Blood Diseases Hospital, China3
Medical College of Wisconsin3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases119
Leukemia21
Myelodysplastic Syndromes20
Leukemia, Myeloid, Acute18
Neoplasms18
Multiple Myeloma14
Lymphoma13
Anemia12
Leukemia, Lymphocytic, Chronic, B-Cell12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive12

Trials

Showing 26 to 50 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.